Overexpression of IDO in endometrial cancer cells may contribute to tumor development in vivo by inhibiting NK cell activity to exert an immunosuppressive effect (Zhan et al., 2020), suggesting that IDO is a novel and reliable prognostic indicator for endometrial cancer. Here, IDO1 is linked to neoplasm.